Zdravka Medarova

Zdravka Medarova has a diverse work experience that spans both the industry and academia. Zdravka is currently serving as the Chief Technology Officer and Co-Founder of TransCode Therapeutics, Inc., a position they have held since October 2021. Prior to that, they worked at Massachusetts General Hospital, where they held various roles. These roles include Associate Professor (since April 2016), Assistant Professor (from April 2010 to April 2016), Instructor (from June 2007 to March 2010), and Postdoctoral Researcher (from December 2002 to May 2007).

Zdravka Medarova pursued higher education, starting with a Bachelor's degree that they obtained between 1995 and 1998 from the University of Southern Maine. Zdravka'sfield of study during this period was Pre-Medicine. Following this, they enrolled at the University of New Hampshire and completed their Doctor of Philosophy (PhD) in Genetics between 1998 and 2002.